Praphathip EamsobhanaAnchalee TungtrongchitrHoi Sen YongAnchana PrasartvitDarawan WanachiwanawinXiao Xian GanZhejiang Academy of Medical SciencesUniversity of MalayaThailand Ministry of Public HealthFaculty of Medicine, Siriraj Hospital, Mahidol University2020-11-182020-11-182020-01-01Parasitology. (2020)14698161003118202-s2.0-85092725739https://repository.li.mahidol.ac.th/handle/20.500.14594/59840© 2020 Cambridge University Press. All rights reserved. Serological tests may yield false-negative results for specific antibodies detection before or at early seroconversion phase. Tests that detect circulating antigens of Angiostrongylus cantonensis would therefore be of value in diagnosis to distinguish current or past infection. Here, a quick, easy to perform, portable and inexpensive diagnostic device for detection of 31-kDa A. cantonensis specific antigens had been developed. This sandwich dot-immunogold filtration assay (AcDIGFAAg), for detecting active angiostrongyliasis was produced using anti-A. cantonensis polyclonal antibody dotted on nitrocellulose membrane as a capture agent and colloidal gold-labeled anti-31 kDa A. cantonensis antibody as a detection agent. A well-defined pink dot, indicating positivity, was seen readily by naked eye within 10-15 min. The AcDIGFAAg detected A. cantonensis specific antigens in CSF samples from four of 10 serologically confirmed angiostrongyliasis cases and two of five suspected cases with negative anti-A. cantonensis antibodies. Among the 19 patient sera with A. cantonensis infection, two showed positive reaction by AcDIGFAAg. No positive AcDIGFAAg reaction was observed in all the serum samples with other parasitic diseases, and the healthy controls. The present “AcDIGFAAg” enables rapid qualitative detection of the specific 31-kDa antigens of A. cantonensis in clinical samples with potential for application even under resource-limited settings.Mahidol UniversityAgricultural and Biological SciencesImmunology and MicrobiologyMedicineSandwich dot-immunogold filtration assay (DIGFA) for specific immunodiagnosis of active neuroangiostrongyliasisArticleSCOPUS10.1017/S0031182020001894